No black box warning on record for Imkeldi

As of the latest FDA labeling reviewed, Imkeldi (IMATINIB ORAL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Imkeldi medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Fluid Retention and Edema: Edema and severe fluid retention have occurred. Weigh patients regularly and manage unexpected rapid weight gain by drug interruption and diuretics. ( 5.1 , 6.1 ) Hematologic Toxicity: Cytopenias, particularly anemia, neutropenia, and thrombocytopenia, have occurred. Manage with dose reduction, dose interruption, or discontinuation of treatment

No black box warning on record for Imkeldi

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Fluid Retention and Edema: Edema and severe fluid retention have occurred. Weigh patients regularly and manage unexpected rapid weight gain by drug interruption and diuretics. ( 5.1 , 6.1 ) Hematologic Toxicity: Cytopenias, particularly anemia, neutropenia, and thrombocytopenia, have occurred. Manage with dose reduction, dose interruption, or discontinuation of treatment

Imkeldi Black Box Warning

No black box warning on record for Imkeldi

Other warnings & precautions

Imkeldi Black Box Warning

No black box warning on record for Imkeldi

Other warnings & precautions